Imaging Services


Swiss imaging and lab groups sigh with relief

A new outpatient tariff which would have taken 6-10% points off imaging prices has been kicked down the road for the third time by the byzantine Swiss healthcare system. It would have severely clipped the very high margins enjoyed by many whilst upping prices for primary care.

Warsaw hub model set to spread across CEE

A new Warsaw Health Innovation Hub in Poland has seen 30 big pharma and medtech contribute brains and money to tackle healthcare projects, extending the cooperation which developed during Covid between the government and the private sector. Healthcare providers are set to join. The model is likely to be adopted by other CEE countries.

Althea to be sold to Inframedica Sarl

Private equity firm Permira has agreed to sell healthcare equipment service provider Althea to oncology platform Inframedica Sarl, which is owned by infrastructure investors F2i and DWS.

Two new rival hospitals open in central London

This week UK healthcare charity Nuffield Trust opened a hospital in its first central London site, located within the grounds of Barts Health NHS Trust’s St Bartholomew’s Hospital site, while Cleveland Clinic last week opened a large facility in Grosvenor Place, also in central London.

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.

Interview: Giuseppe Recchi, CEO, Affidea

In light of multinational diagnostic imaging provider Affidea's recent acquisition of Brust Zentrum, a Zurich-based breast cancer care provider, we speak to CEO Giuseppe Recchi about the company's vision to create a pan-European polydiagnostic outpatient platform.

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.

Atrys: What’s the focus?

No listed health care group in Europe has grown anything like as fast as Atrys Health, which now spans Spain, Portugal, Switzerland and four Latin American countries. But does its M&A strategy have any coherence? We talk to Atrys CFO Josep Maria Huch.

Find Us